We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESI icon
301
Element Solutions
ESI
$9.23B
$11.5M 0.06%
987,833
+713,341
+260% +$7.78M
SKM icon
302
SK Telecom
SKM
$13.2B
$11.4M 0.06%
297,718
+237,053
+391% +$9.21M
FFIV icon
303
F5
FFIV
$22.7B
$11.4M 0.06%
66,219
-90,469
-58% -$15.1M
WMT icon
304
Walmart Inc
WMT
$890B
$11.4M 0.06%
+399,336
New +$11.4M
GSKY
305
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$11.4M 0.06%
+538,824
New +$12.9M
SBLK icon
306
Star Bulk Carriers
SBLK
$3.22B
$11.4M 0.06%
885,029
+834,569
+1,654% +$10.6M
IP icon
307
International Paper
IP
$22B
$11.3M 0.06%
229,434
-230,506
-50% -$11.8M
TGE
308
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$11.3M 0.06%
510,330
+411,444
+416% +$8.72M
AEE icon
309
Ameren
AEE
$30.1B
$11.3M 0.06%
+185,326
New +$10.7M
KEY icon
310
KeyCorp
KEY
$24.4B
$11.2M 0.06%
575,093
+162,436
+39% +$3.24M
KO icon
311
Coca-Cola
KO
$375B
$11.2M 0.06%
254,999
-110,700
-30% -$4.78M
PM icon
312
Philip Morris
PM
$295B
$11.1M 0.06%
138,022
-1,122,550
-89% -$95.3M
PBYI icon
313
Puma Biotechnology
PBYI
$454M
$11.1M 0.06%
187,245
+112,006
+149% +$6.49M
CSTM icon
314
Constellium
CSTM
$3.99B
$11.1M 0.06%
1,075,080
-23,167
-2% -$269K
NTAP icon
315
NetApp
NTAP
$37.2B
$11M 0.06%
140,522
-23,336
-14% -$1.64M
KOS icon
316
Kosmos Energy
KOS
$1.48B
$11M 0.06%
1,325,841
+789,222
+147% +$5.76M
TEVA icon
317
Teva Pharmaceuticals
TEVA
$41.2B
$10.9M 0.06%
+449,276
New +$9.16M
MMS icon
318
Maximus
MMS
$3.11B
$10.9M 0.06%
175,839
+148,226
+537% +$9.61M
EXPE icon
319
Expedia Group
EXPE
$37.3B
$10.9M 0.06%
90,848
+29,231
+47% +$3.38M
CPE
320
DELISTED
Callon Petroleum Company
CPE
$10.7M 0.06%
99,366
+82,063
+474% +$10.2M
RJF icon
321
Raymond James Financial
RJF
$34B
$10.6M 0.06%
178,502
-102,301
-36% -$6.35M
ACRS icon
322
Aclaris Therapeutics
ACRS
$825M
$10.6M 0.06%
531,210
-155,381
-23% -$2.87M
CBM
323
DELISTED
Cambrex Corporation
CBM
$10.5M 0.06%
+201,269
New +$10M
G icon
324
Genpact
G
$5.81B
$10.5M 0.06%
+362,806
New +$11.2M
TVTY
325
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$10.4M 0.06%
294,915
+93,191
+46% +$3.44M
11 12
13
14 15

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.